Line 2,580: |
Line 2,580: |
| !'''Date of Last Editor Review''' | | !'''Date of Last Editor Review''' |
| !'''Notes''' | | !'''Notes''' |
− | |- |Astrocytoma, IDH-mutant||Disease||
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
− | |Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease|| | + | |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease|| |
| | | | | |
| | | | | |
Line 2,598: |
Line 2,590: |
| | | | | |
| |- | | |- |
− | |Glioblastoma, IDH-wildtype||Disease|| | + | |Glioblastoma, IDH-Wildtype||Disease|| |
| | | | | |
| | | | | |
Line 2,607: |
Line 2,599: |
| | | | | |
| |- | | |- |
− | |Diffuse astrocytoma, MYB- or MYBL1-altered||Disease|| | + | |Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease|| |
| | | | | |
| | | | | |
Line 2,616: |
Line 2,608: |
| | | | | |
| |- | | |- |
− | |Angiocentric glioma||Disease|| | + | |Angiocentric Glioma||Disease|| |
| | | | | |
| | | | | |
Line 2,625: |
Line 2,617: |
| | | | | |
| |- | | |- |
− | |Polymorphous low-grade neuroepithelial tumour of the young||Disease|| | + | |Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease|| |
| | | | | |
| | | | | |
Line 2,634: |
Line 2,626: |
| | | | | |
| |- | | |- |
− | |Diffuse low-grade glioma, MAPK pathway-altered||Disease|| | + | |Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease|| |
| | | | | |
| | | | | |
Line 2,643: |
Line 2,635: |
| | | | | |
| |- | | |- |
− | |Diffuse midline glioma, H3 K27-altered||Disease|| | + | |Diffuse Midline Glioma, H3 K27-Altered||Disease|| |
| | | | | |
| | | | | |
Line 2,652: |
Line 2,644: |
| | | | | |
| |- | | |- |
− | |Diffuse hemispheric glioma, H3 G34-mutant||Disease|| | + | |Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease|| |
| | | | | |
| | | | | |
Line 2,661: |
Line 2,653: |
| | | | | |
| |- | | |- |
− | |Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease|| | + | |Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease|| |
| | | | | |
| | | | | |
Line 2,670: |
Line 2,662: |
| | | | | |
| |- | | |- |
− | |Infant-type hemispheric glioma||Disease|| | + | |Infant-Type Hemispheric Glioma||Disease|| |
| | | | | |
| | | | | |
Line 2,679: |
Line 2,671: |
| | | | | |
| |- | | |- |
− | |Pilocytic astrocytoma||Disease|| | + | |Pilocytic Astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,688: |
Line 2,680: |
| | | | | |
| |- | | |- |
− | |High-grade astrocytoma with piloid features||Disease|| | + | |High-Grade Astrocytoma with Piloid Features||Disease|| |
| | | | | |
| | | | | |
Line 2,697: |
Line 2,689: |
| | | | | |
| |- | | |- |
− | |Pleomorphic xanthoastrocytoma||Disease|| | + | |Pleomorphic Xanthoastrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,706: |
Line 2,698: |
| | | | | |
| |- | | |- |
− | |Subependymal giant cell astrocytoma||Disease|| | + | |Subependymal Giant Cell Astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,715: |
Line 2,707: |
| | | | | |
| |- | | |- |
− | |Chordoid glioma||Disease|| | + | |Chordoid Glioma||Disease|| |
| | | | | |
| | | | | |
Line 2,724: |
Line 2,716: |
| | | | | |
| |- | | |- |
− | |Astroblastoma, MN1-altered||Disease|| | + | |Astroblastoma, MN1-Altered||Disease|| |
| | | | | |
| | | | | |
Line 2,751: |
Line 2,743: |
| | | | | |
| |- | | |- |
− | |Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease|| | + | |Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,760: |
Line 2,752: |
| | | | | |
| |- | | |- |
− | |Dysembryoplastic neuroepithelial tumour||Disease|| | + | |Dysembryoplastic Neuroepithelial Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,769: |
Line 2,761: |
| | | | | |
| |- | | |- |
− | |Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease|| | + | |Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease|| |
| | | | | |
| | | | | |
Line 2,778: |
Line 2,770: |
| | | | | |
| |- | | |- |
− | |Papillary glioneuronal tumour||Disease|| | + | |Papillary Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,787: |
Line 2,779: |
| | | | | |
| |- | | |- |
− | |Rosette-forming glioneuronal tumour||Disease|| | + | |Rosette-Forming Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,796: |
Line 2,788: |
| | | | | |
| |- | | |- |
− | |Myxoid glioneuronal tumour||Disease|| | + | |Myxoid Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,805: |
Line 2,797: |
| | | | | |
| |- | | |- |
− | |Diffuse leptomeningeal glioneuronal tumour||Disease|| | + | |Diffuse Lptomeningeal Glioneuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,814: |
Line 2,806: |
| | | | | |
| |- | | |- |
− | |Multinodular and vacuolating neuronal tumour||Disease|| | + | |Multinodular and Vacuolating Neuronal Tumour||Disease|| |
| | | | | |
| | | | | |
Line 2,823: |
Line 2,815: |
| | | | | |
| |- | | |- |
− | |Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease|| | + | |Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease|| |
| | | | | |
| | | | | |
Line 2,832: |
Line 2,824: |
| | | | | |
| |- | | |- |
− | |Central neurocytoma||Disease|| | + | |Central Neurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,841: |
Line 2,833: |
| | | | | |
| |- | | |- |
− | |Extraventricular neurocytoma||Disease|| | + | |Extraventricular Neurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,850: |
Line 2,842: |
| | | | | |
| |- | | |- |
− | |Cerebellar liponeurocytoma||Disease|| | + | |Cerebellar Liponeurocytoma||Disease|| |
| | | | | |
| | | | | |
Line 2,859: |
Line 2,851: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma||Disease|| | + | |Supratentorial Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,868: |
Line 2,860: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma, ZFTA fusion-positive||Disease|| | + | |Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease|| |
| | | | | |
| | | | | |
Line 2,877: |
Line 2,869: |
| | | | | |
| |- | | |- |
− | |Supratentorial ependymoma, YAP1 fusion-positive||Disease|| | + | |Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease|| |
| | | | | |
| | | | | |
Line 2,886: |
Line 2,878: |
| | | | | |
| |- | | |- |
− | |Posterior fossa ependymoma||Disease|| | + | |Posterior Fossa Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,895: |
Line 2,887: |
| | | | | |
| |- | | |- |
− | |Posterior fossa group A (PFA) ependymoma||Disease|| | + | |Posterior Fossa Group A (PFA) Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,904: |
Line 2,896: |
| | | | | |
| |- | | |- |
− | |Posterior fossa group B (PFB) ependymoma||Disease|| | + | |Posterior Fossa Group B (PFB) Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,913: |
Line 2,905: |
| | | | | |
| |- | | |- |
− | |Spinal ependymoma||Disease|| | + | |Spinal Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,922: |
Line 2,914: |
| | | | | |
| |- | | |- |
− | |Spinal ependymoma, MYCN-amplified||Disease|| | + | |Spinal Ependymoma, MYCN-Amplified||Disease|| |
| | | | | |
| | | | | |
Line 2,931: |
Line 2,923: |
| | | | | |
| |- | | |- |
− | |Myxopapillary ependymoma||Disease|| | + | |Myxopapillary Ependymoma||Disease|| |
| | | | | |
| | | | | |
Line 2,949: |
Line 2,941: |
| | | | | |
| |- | | |- |
− | |Choroid plexus papilloma||Disease|| | + | |Choroid Plexus Papilloma||Disease|| |
| | | | | |
| | | | | |
Line 2,958: |
Line 2,950: |
| | | | | |
| |- | | |- |
− | |Atypical choroid plexus papilloma||Disease|| | + | |Atypical Choroid Plexus Papilloma||Disease|| |
| | | | | |
| | | | | |
Line 2,967: |
Line 2,959: |
| | | | | |
| |- | | |- |
− | |Choroid plexus carcinoma||Disease|| | + | |Choroid Plexus Carcinoma||Disease|| |
| | | | | |
| | | | | |
Line 2,976: |
Line 2,968: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, WNT-activated||Disease|| | + | |Medulloblastoma, WNT-Activated||Disease|| |
| | | | | |
| | | | | |
Line 2,985: |
Line 2,977: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, SHH-activated and TP53-wildtype||Disease|| | + | |Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease|| |
| | | | | |
| | | | | |
Line 2,994: |
Line 2,986: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, SHH-activated and TP53-mutant||Disease|| | + | |Medulloblastoma, SHH-Activated and TP53-Mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,003: |
Line 2,995: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, non-WNT/non-SHH||Disease|| | + | |Medulloblastoma, Non-WNT/Non-SHH||Disease|| |
| | | | | |
| | | | | |
Line 3,012: |
Line 3,004: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, histologically defined||Disease|| | + | |Medulloblastoma, Histologically Defined||Disease|| |
| | | | | |
| | | | | |
Line 3,021: |
Line 3,013: |
| | | | | |
| |- | | |- |
− | |Atypical teratoid/rhabdoid tumour||Disease|| | + | |Atypical Teratoid/Rhabdoid Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,030: |
Line 3,022: |
| | | | | |
| |- | | |- |
− | |Cribriform neuroepithelial tumour||Disease|| | + | |Cribriform Neuroepithelial Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,039: |
Line 3,031: |
| | | | | |
| |- | | |- |
− | |Embryonal tumour with multilayered rosettes||Disease|| | + | |Embryonal Tumour with Multilayered Rosettes||Disease|| |
| | | | | |
| | | | | |
Line 3,048: |
Line 3,040: |
| | | | | |
| |- | | |- |
− | |CNS neuroblastoma, FOXR2-activated||Disease|| | + | |CNS Neuroblastoma, FOXR2-Activated||Disease|| |
| | | | | |
| | | | | |
Line 3,057: |
Line 3,049: |
| | | | | |
| |- | | |- |
− | |CNS tumour with BCOR internal tandem duplication||Disease|| | + | |CNS Tumour with BCOR Internal Tandem Duplication||Disease|| |
| | | | | |
| | | | | |
Line 3,066: |
Line 3,058: |
| | | | | |
| |- | | |- |
− | |CNS embryonal tumour NEC/NOS||Disease|| | + | |CNS Embryonal Tumour NEC/NOS||Disease|| |
| | | | | |
| | | | | |
Line 3,084: |
Line 3,076: |
| | | | | |
| |- | | |- |
− | |Pineal parenchymal tumour of intermediate differentiation||Disease|| | + | |Pineal Parenchymal Tumour of Intermediate Differentiation||Disease|| |
| | | | | |
| | | | | |
Line 3,102: |
Line 3,094: |
| | | | | |
| |- | | |- |
− | |Papillary tumour of the pineal region||Disease|| | + | |Papillary Tumour of the Pineal Region||Disease|| |
| | | | | |
| | | | | |
Line 3,111: |
Line 3,103: |
| | | | | |
| |- | | |- |
− | |Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease|| | + | |Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,147: |
Line 3,139: |
| | | | | |
| |- | | |- |
− | |Hybrid nerve sheath tumours||Disease|| | + | |Hybrid Nerve Sheath Tumours||Disease|| |
| | | | | |
| | | | | |
Line 3,156: |
Line 3,148: |
| | | | | |
| |- | | |- |
− | |Malignant melanotic nerve sheath tumour||Disease|| | + | |Malignant Melanotic Nerve Sheath Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,165: |
Line 3,157: |
| | | | | |
| |- | | |- |
− | |Malignant peripheral nerve sheath tumour||Disease|| | + | |Malignant Peripheral Nerve Sheath Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,174: |
Line 3,166: |
| | | | | |
| |- | | |- |
− | |Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease|| | + | |Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease|| |
| | | | | |
| | | | | |
Line 3,192: |
Line 3,184: |
| | | | | |
| |- | | |- |
− | |Solitary fibrous tumour||Disease|| | + | |Solitary Fibrous Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,201: |
Line 3,193: |
| | | | | |
| |- | | |- |
− | |Haemangiomas and vascular malformations||Disease|| | + | |Haemangiomas and Vascular Malformations||Disease|| |
| | | | | |
| | | | | |
Line 3,228: |
Line 3,220: |
| | | | | |
| |- | | |- |
− | |Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease|| | + | |Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease|| |
| | | | | |
| | | | | |
Line 3,237: |
Line 3,229: |
| | | | | |
| |- | | |- |
− | |CIC-rearranged sarcoma||Disease|| | + | |CIC-Rearranged Sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,246: |
Line 3,238: |
| | | | | |
| |- | | |- |
− | |Primary intracranial sarcoma, DICER1-mutant||Disease|| | + | |Primary Intracranial Sarcoma, DICER1-Mutant||Disease|| |
| | | | | |
| | | | | |
Line 3,255: |
Line 3,247: |
| | | | | |
| |- | | |- |
− | |Ewing sarcoma||Disease|| | + | |Ewing Sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,264: |
Line 3,256: |
| | | | | |
| |- | | |- |
− | |Mesenchymal chondrosarcoma||Disease|| | + | |Mesenchymal Chondrosarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,291: |
Line 3,283: |
| | | | | |
| |- | | |- |
− | |Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease|| | + | |Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,300: |
Line 3,292: |
| | | | | |
| |- | | |- |
− | |Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease|| | + | |Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease|| |
| | | | | |
| | | | | |
Line 3,309: |
Line 3,301: |
| | | | | |
| |- | | |- |
− | |Primary diffuse large B-cell lymphoma of the CNS||Disease|| | + | |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,318: |
Line 3,310: |
| | | | | |
| |- | | |- |
− | |Immunodeficiency-associated CNS lymphomas||Disease|| | + | |Immunodeficiency-Associated CNS Lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 3,327: |
Line 3,319: |
| | | | | |
| |- | | |- |
− | |Lymphomatoid granulomatosis||Disease|| | + | |Lymphomatoid Granulomatosis||Disease|| |
| | | | | |
| | | | | |
Line 3,336: |
Line 3,328: |
| | | | | |
| |- | | |- |
− | |Intravascular large B-cell lymphoma||Disease|| | + | |Intravascular Large B-cell Lymphoma||Disease|| |
| | | | | |
| | | | | |
Line 3,345: |
Line 3,337: |
| | | | | |
| |- | | |- |
− | |MALT lymphoma of the dura||Disease|| | + | |MALT Lymphoma of the Dura||Disease|| |
| | | | | |
| | | | | |
Line 3,354: |
Line 3,346: |
| | | | | |
| |- | | |- |
− | |Other low-grade B-cell lymphomas of the CNS||Disease|| | + | |Other Low-Grade B-cell Lymphomas of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,363: |
Line 3,355: |
| | | | | |
| |- | | |- |
− | |Anaplastic large cell lymphoma (ALK+/ALK−)||Disease|| | + | |Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease|| |
| | | | | |
| | | | | |
Line 3,372: |
Line 3,364: |
| | | | | |
| |- | | |- |
− | |T-cell and NK/T-cell lymphomas||Disease|| | + | |T-cell and NK/T-cell Lymphomas||Disease|| |
| | | | | |
| | | | | |
Line 3,381: |
Line 3,373: |
| | | | | |
| |- | | |- |
− | |Erdheim-Chester disease||Disease|| | + | |Erdheim-Chester Disease||Disease|| |
| | | | | |
| | | | | |
Line 3,390: |
Line 3,382: |
| | | | | |
| |- | | |- |
− | |Rosai-Dorfman disease||Disease|| | + | |Rosai-Dorfman Disease||Disease|| |
| | | | | |
| | | | | |
Line 3,399: |
Line 3,391: |
| | | | | |
| |- | | |- |
− | |Juvenile xanthogranuloma||Disease|| | + | |Juvenile Xanthogranuloma||Disease|| |
| | | | | |
| | | | | |
Line 3,408: |
Line 3,400: |
| | | | | |
| |- | | |- |
− | |Langerhans cell histiocytosis||Disease|| | + | |Langerhans Cell Histiocytosis||Disease|| |
| | | | | |
| | | | | |
Line 3,417: |
Line 3,409: |
| | | | | |
| |- | | |- |
− | |Histiocytic sarcoma||Disease|| | + | |Histiocytic Sarcoma||Disease|| |
| | | | | |
| | | | | |
Line 3,426: |
Line 3,418: |
| | | | | |
| |- | | |- |
− | |Germ cell tumours of the CNS||Disease|| | + | |Germ Cell Tumours of the CNS||Disease|| |
| | | | | |
| | | | | |
Line 3,435: |
Line 3,427: |
| | | | | |
| |- | | |- |
− | |Adamantinomatous craniopharyngioma||Disease|| | + | |Adamantinomatous Craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,444: |
Line 3,436: |
| | | | | |
| |- | | |- |
− | |Papillary craniopharyngioma||Disease|| | + | |Papillary Craniopharyngioma||Disease|| |
| | | | | |
| | | | | |
Line 3,453: |
Line 3,445: |
| | | | | |
| |- | | |- |
− | |Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease|| | + | |Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease|| |
| | | | | |
| | | | | |
Line 3,462: |
Line 3,454: |
| | | | | |
| |- | | |- |
− | |Pituitary adenoma / pituitary neuroendocrine tumour||Disease|| | + | |Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease|| |
| | | | | |
| | | | | |
Line 3,471: |
Line 3,463: |
| | | | | |
| |- | | |- |
− | |Pituitary blastoma||Disease|| | + | |Pituitary Blastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,480: |
Line 3,472: |
| | | | | |
| |- | | |- |
− | |Metastases to the brain and spinal cord parenchyma||Disease|| | + | |Metastases to the Brain and Spinal Cord Parenchyma||Disease|| |
| | | | | |
| | | | | |
Line 3,489: |
Line 3,481: |
| | | | | |
| |- | | |- |
− | |Metastases to the meninges||Disease|| | + | |Metastases to the Meninges||Disease|| |
| | | | | |
| | | | | |
Line 3,498: |
Line 3,490: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis type 1||Disease|| | + | |Neurofibromatosis Type 1||Disease|| |
| | | | | |
| | | | | |
Line 3,507: |
Line 3,499: |
| | | | | |
| |- | | |- |
− | |Neurofibromatosis type 2||Disease|| | + | |Neurofibromatosis Type 2||Disease|| |
| | | | | |
| | | | | |
Line 3,525: |
Line 3,517: |
| | | | | |
| |- | | |- |
− | |Von Hippel-Lindau syndrome||Disease|| | + | |Von Hippel-Lindau Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,534: |
Line 3,526: |
| | | | | |
| |- | | |- |
− | |Tuberous sclerosis||Disease|| | + | |Tuberous Sclerosis||Disease|| |
| | | | | |
| | | | | |
Line 3,543: |
Line 3,535: |
| | | | | |
| |- | | |- |
− | |Li-Fraumeni syndrome||Disease|| | + | |Li-Fraumeni Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,552: |
Line 3,544: |
| | | | | |
| |- | | |- |
− | |Cowden syndrome||Disease|| | + | |Cowden Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,561: |
Line 3,553: |
| | | | | |
| |- | | |- |
− | |Constitutional mismatch repair deficiency syndrome||Disease|| | + | |Constitutional Mismatch Repair Deficiency Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,570: |
Line 3,562: |
| | | | | |
| |- | | |- |
− | |Familial adenomatous polyposis 1||Disease|| | + | |Familial Adenomatous Polyposis 1||Disease|| |
| | | | | |
| | | | | |
Line 3,579: |
Line 3,571: |
| | | | | |
| |- | | |- |
− | |Naevoid basal cell carcinoma syndrome||Disease|| | + | |Naevoid Basal Cell Carcinoma Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,588: |
Line 3,580: |
| | | | | |
| |- | | |- |
− | |Rhabdoid tumour predisposition syndrome||Disease|| | + | |Rhabdoid Tumour Predisposition Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,597: |
Line 3,589: |
| | | | | |
| |- | | |- |
− | |Carney complex||Disease|| | + | |Carney Complex||Disease|| |
| | | | | |
| | | | | |
Line 3,606: |
Line 3,598: |
| | | | | |
| |- | | |- |
− | |DICER1 syndrome||Disease|| | + | |DICER1 Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,615: |
Line 3,607: |
| | | | | |
| |- | | |- |
− | |Familial paraganglioma syndromes||Disease|| | + | |Familial Paraganglioma Syndromes||Disease|| |
| | | | | |
| | | | | |
Line 3,624: |
Line 3,616: |
| | | | | |
| |- | | |- |
− | |Melanoma-astrocytoma syndrome||Disease|| | + | |Melanoma-Astrocytoma Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,633: |
Line 3,625: |
| | | | | |
| |- | | |- |
− | |Familial retinoblastoma||Disease|| | + | |Familial Retinoblastoma||Disease|| |
| | | | | |
| | | | | |
Line 3,642: |
Line 3,634: |
| | | | | |
| |- | | |- |
− | |BAP1 tumour predisposition syndrome||Disease|| | + | |BAP1 Tumour Predisposition Syndrome||Disease|| |
| | | | | |
| | | | | |
Line 3,651: |
Line 3,643: |
| | | | | |
| |- | | |- |
− | |Fanconi anaemia||Disease|| | + | |Fanconi Anaemia||Disease|| |
| | | | | |
| | | | | |
Line 3,660: |
Line 3,652: |
| | | | | |
| |- | | |- |
− | |ELP1-medulloblastoma syndrome||Disease|| | + | |ELP1-Medulloblastoma Syndrome||Disease|| |
| | | | | |
| | | | | |